mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |